Pedro Cuatrecasas

Pedro Cuatrecasas

Pedro Martin Cuatrecasas (born September 27, 1936 in Madrid ) is an American physician and pharmacologist .

Career

Cuatrecasas studied medicine at the University of Washington in St. Louis , where he received his bachelor's degree in 1958 and his doctorate in 1962 (MD, magna cum laude ). He was then from 1962 to 1964 internship (residency) at Johns Hopkins University Hospital and then researched at the National Institutes of Health (Institute for Arthritis and Metabolic Diseases), from 1967 as Medical Officer, while at the same time at George Washington University lecturer in biochemistry. From 1970 he was Associate Professor and from 1972 Professor at the Johns Hopkins University Medical School. From 1975 to 1986 he was Research Director at Wellcome Burroughs at their research laboratories in North Carolina (Vice President for Research) and at the same time Adjunct Professor at Duke University and the University of North Carolina . From 1986 he was Senior Vice President for Research at Glaxo and in 1988/89 Director of Glaxo International Research. From 1989 to 1997 he was President of Pharmaceutical Research at Parke-Davis in Ann Arbor and from 1989 to 1997 Vice President of Warner-Lambert. From 1990 he was also adjunct professor at the University of Michigan and from 1997 at the University of California, San Diego .

He is known for the invention and development of affinity chromatography . During his time in the pharmaceutical industry, he was involved in the development and launch of over 40 drugs, including acyclovir and AZT .

In 1987 he received the Wolf Prize in Medicine with Meir Wilchek . In 1972 he received the John J. Abel Award in Pharmacology. In 1982 he was elected to the National Academy of Sciences and in 1988 to the American Academy of Arts and Sciences .

Web links

• Page at UCSD ( Memento from December 29, 2014 in the Internet Archive )